Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 4 7Phase 3 2Phase 2 2Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Tumor-Agnostic 1Thoracic 1Other neoplasm 1Gynecologic 1

Conditions

Rectal Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 309Oxaliplatin 260Leucovorin 234Capecitabine 198Irinotecan 147Gemcitabine 128Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 64Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 42S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36130-nm albumin-bound paclitaxel 29Surgical Procedures, Operative 27regorafenib 25lenvatinib 24XELOX 24Radiation 24Panitumumab 24Nivolumab 23atezolizumab 22Carboplatin 22trifluridine tipiracil drug combination 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Propofol × Gastrointestinal × Clear all
NCT04316013 2025-03-14

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial

Peter MacCallum Cancer Centre, Australia

Phase 3 Terminated
254 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Rectal Neoplasms

NCT04513808 2024-12-04

Total Intravenous Anesthesia and Recurrence Free Survival

The Cleveland Clinic

Phase 3 Recruiting
1,614 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡